<![CDATA[Q1 2026: 5 FDA Decisions to Watch in the Realm of Oncology]]>
As Q1 begins, the oncology community is closely watching the FDA for several key regulatory decisions. With potential approvals spanning a range of therapeutic areas, the next few months could introduce new treatment options and reshape current standards …